Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
396.97
437.35
397.39
375.52
393.13
475.49
425.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
396.97
437.35
397.39
375.52
393.13
475.49
425.48
Raw Material Cost
172.09
166.24
102.53
145.42
161.06
150.45
125.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.24
6.59
5.72
6.13
5.34
6.10
1.59
Selling and Distribution Expenses
183.65
180.57
217.66
181.10
156.97
191.68
224.42
Other Expenses
3.83
3.28
3.34
4.30
3.78
3.65
7.15
Total Expenditure (Excl Depreciation)
401.29
386.16
359.34
375.67
361.13
384.72
423.32
Operating Profit (PBDIT) excl Other Income
-4.3
51.2
38.1
-0.1
32
90.8
2.2
Other Income
-9.76
15.34
19.84
30.06
5.39
29.28
40.35
Operating Profit (PBDIT)
44.74
129.17
75.22
90.19
97.06
172.58
110.15
Interest
7.24
6.59
5.72
6.13
5.34
6.10
1.59
Exceptional Items
78.28
0.61
0.59
0.49
46.35
1.15
0.97
Gross Profit (PBDT)
224.88
271.11
294.86
230.10
232.07
325.04
299.63
Depreciation
64.72
64.72
61.02
61.02
54.47
54.47
44.31
Profit Before Tax
51.07
58.48
9.07
23.53
83.59
113.15
65.22
Tax
5.26
9.32
3.36
-10.07
9.35
18.51
-2.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
48.28
49.74
7.62
28.60
70.98
91.74
80.17
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
48.28
49.74
7.62
28.60
70.98
91.74
80.17
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-8.76
-7.95
-15.67
-9.37
-8.88
-11.10
-16.97
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
39.52
41.79
-8.05
19.24
62.11
80.63
63.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,994.72
7,163.99
7,116.12
7,130.76
7,254.96
7,341.43
7,243.23
Earnings per share (EPS)
0.08
0.09
0.01
0.04
0.12
0.16
0.14
Diluted Earnings per share
0.08
0.09
0.01
0.04
0.12
0.16
0.14
Operating Profit Margin (Excl OI)
-2.57%
11.23%
-1.42%
-0.23%
9.46%
18.68%
5.99%
Gross Profit Margin
29.17%
28.17%
17.64%
22.52%
35.12%
35.25%
25.74%
PAT Margin
12.16%
11.37%
1.92%
7.62%
18.06%
19.29%
18.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 0.99% vs 20.58% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -36.39% vs -0.16% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -40.57% vs 51.57% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 35.85% vs -10.17% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Sansure Biotech, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
396.97
0
396.97
Other Operating Income
0.00
0.00
0.00
Total Operating income
396.97
0
396.97
Raw Material Cost
172.09
0
172.09
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.24
0
7.24
Selling and Distribution Expenses
183.65
0
183.65
Other Expenses
3.83
0.00
3.83
Total Expenditure (Excl Depreciation)
401.29
0
401.29
Operating Profit (PBDIT) excl Other Income
-4.32
0.00
-4.32
Other Income
-9.76
0
-9.76
Operating Profit (PBDIT)
44.74
0
44.74
Interest
7.24
0
7.24
Exceptional Items
78.28
0
78.28
Gross Profit (PBDT)
224.88
0
224.88
Depreciation
64.72
0
64.72
Profit Before Tax
51.07
0
51.07
Tax
5.26
0
5.26
Provisions and contingencies
0
0
0.00
Profit After Tax
48.28
0
48.28
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
48.28
0
48.28
Share in Profit of Associates
0
0
0.00
Minority Interest
-8.76
0
-8.76
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.52
0
39.52
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,994.72
0
6,994.72
Earnings per share (EPS)
0.08
0
0.08
Diluted Earnings per share
0.08
0
0.08
Operating Profit Margin (Excl OI)
-2.57%
0%
0.00
-2.57%
Gross Profit Margin
29.17%
0%
0.00
29.17%
PAT Margin
12.16%
0%
0.00
12.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 39.70 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -9.22% vs 10.04% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.99% vs 20.58% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.95 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -5.50% vs 616.05% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -36.39% vs -0.16% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.45 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -52.11% vs 105.42% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -40.57% vs 51.57% in Jun 2025
Quarterly - Interest
Interest 0.72 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 9.09% vs 15.79% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 35.85% vs -10.17% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -2.57%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
